Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia

PURPOSE: To investigate the exposure-toxicity relationship of bosutinib and to identify the target trough plasma concentration (C(0)). METHODS: The toxicity and C(0) of bosutinib in Japanese chronic myeloid leukemia (CML) patients were monitored every 2 weeks for the first 3 months of treatment, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mita, Akiko, Abumiya, Maiko, Miura, Masatomo, Niioka, Takenori, Takahashi, Saori, Yoshioka, Tomoko, Kameoka, Yoshihiro, Takahashi, Naoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899348/
https://www.ncbi.nlm.nih.gov/pubmed/29682402
http://dx.doi.org/10.1186/s40164-018-0101-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899348/
https://www.ncbi.nlm.nih.gov/pubmed/29682402
http://dx.doi.org/10.1186/s40164-018-0101-1

Ejemplares similares